STCube Participates in JP Morgan Healthcare Conference... "Conducting Meetings with Global Pharmaceutical Companies"
[Asia Economy Reporter Hyunseok Yoo] STCube, a bio company developing immune checkpoint inhibitors, announced on the 7th that it will participate in the 'JP Morgan Healthcare Conference 2020' held in San Francisco, USA, starting on the 13th, and hold meetings with global pharmaceutical companies and institutional investors.
STCube plans to send a large-scale workforce including key researchers to this conference and share information on the research and development of immune checkpoint inhibitors.
STCube, which is conducting research on immune checkpoint inhibitor pipelines jointly with the world’s top cancer research institution, the MD Anderson Cancer Center in the USA, will explain the research status of its newly discovered immune anticancer agent STT-003 antibody, as well as its PD-1, PD-L1 antibodies and multiple other pipelines at this conference.
The immune checkpoint inhibitors, new anticancer drug substances being researched by STCube, are anticancer agents that inhibit immune checkpoints created by cancer cells to block attacks from immune cells, thereby enabling immune cells to effectively attack cancer cells. Currently marketed immune checkpoint inhibitors have high anticancer effects and have begun to be used as basic treatments for cancer patients. These substances are being intensively developed by numerous global pharmaceutical companies and academia.
A company official stated, "Many companies that participated in past JP Morgan Healthcare Conferences have signed technology transfer and joint research and development contracts with global pharmaceutical companies," and added, "We will actively discuss various business cooperation plans and investments regarding our pipelines through this conference."
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
Now in its 38th year, the JP Morgan Healthcare Conference is the world’s largest healthcare investment conference, with participation from over 1,500 pharmaceutical and healthcare service companies worldwide every year. Companies participating in the conference introduce their pipelines to global pharmaceutical companies and institutional investors and discuss research cooperation and investment attraction.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
